Year To Quarter End Consolidated Statement Of Comprehensive Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7714030

Concept 2018-04-01 to
2018-12-31
2017-04-01 to
2017-12-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
5,112,000,000 JPY
6,119,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-1,813,000,000 JPY
1,506,000,000 JPY
Foreign currency translation adjustment
10,000,000 JPY
-36,000,000 JPY
Remeasurements of defined benefit plans, net of tax
396,000,000 JPY
474,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-12,000,000 JPY
2,000,000 JPY
Other comprehensive income
-1,418,000,000 JPY
1,948,000,000 JPY
Comprehensive income
3,694,000,000 JPY
8,068,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,694,000,000 JPY
8,068,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.